[HTML][HTML] Roles of the dynamic tumor immune microenvironment in the individualized treatment of advanced clear cell renal cell carcinoma
E Lin, X Liu, Y Liu, Z Zhang, L Xie, K Tian… - Frontiers in …, 2021 - frontiersin.org
Immune checkpoint inhibitors (ICIs) are currently a first-line treatment option for clear cell
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …
[HTML][HTML] Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma
E Lin, X Liu, Y Liu, Z Zhang, L Xie, K Tian… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are currently a first-line treatment option for clear cell
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …
Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma
E Lin, X Liu, Y Liu, Z Zhang, L Xie… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are currently a first-line treatment option for clear cell
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …
Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma.
E Lin, X Liu, Y Liu, Z Zhang, L Xie, K Tian… - Frontiers in …, 2021 - europepmc.org
Immune checkpoint inhibitors (ICIs) are currently a first-line treatment option for clear cell
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …
Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma
E Lin, X Liu, Y Liu, Z Zhang, L Xie, K Tian… - Manipulating the …, 2022 - books.google.com
Immune checkpoint inhibitors (ICIs) are currently a first-line treatment option for clear cell
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …
renal cell carcinoma (ccRCC). However, recent clinical studies have shown that a large …